r Excitatory amino acid transporter 2 (EAAT2) is present on astrocytes in the nucleus tractus solitarii (nTS), an important nucleus in cardiorespiratory control. Its specific role in influencing nTS neuronal activity and thereby basal and reflex cardiorespiratory function is unknown.
Introduction
The nucleus tractus solitarii (nTS) is the first central synaptic connection for multiple visceral afferents including cardiovascular, respiratory and digestive reflexes (Andresen & Kunze, 1994; Travagli et al. 2006) , and is a key site of integration and modulation of this sensory afferent information. Glutamate (Glu) is the primary excitatory neurotransmitter in the nTS including solitary tract afferent terminals (Andresen & Mendelowitz, 1996) . It is removed from the extrasynaptic milieu by excitatory amino acid transporters (EAATs) (Danbolt, 2001) . Of the five known EAATs, EAAT1 and 2 have been demonstrated on astrocytes in the nTS while EAAT3 is found on nTS neurons (Chounlamountry & Kessler, 2011; . The capability of astrocytes to modulate synaptic activity throughout the central nervous system has been increasingly recognized (Nedergaard et al. 2003; Martin et al. 2007; Potapenko et al. 2013 ) and the interaction of astrocytes with pre-and postsynaptic neurons is referred to as the tripartite synapse (Halassa et al. 2007; Perea et al. 2009 ).
We and others demonstrated that EAATs are important for restraining excitatory activity within the nTS (Huda et al. 2013; . However, whether a specific EAAT mediates modulation of synaptic, neuronal and physiological activity as well as its ability to influence cardiorespiratory reflex function remains unclear. In the majority of the CNS, EAAT2 plays a greater role in glutamate uptake than EAAT1 (Otis & Kavanaugh, 2000; Zhou & Danbolt, 2013) . Therefore, we hypothesized that the effects of general EAAT blockade, namely increased nTS excitation in vitro with corresponding depressor and sympathoinhibitory effects in vivo, were likely to be mediated primarily by EAAT2. We further hypothesized that astrocytic EAAT2 dampens nTS neuronal activity and glutamate-mediated cardiorespiratory reflex responses in vivo. Here, we demonstrate that EAAT2 reduces activation of postsynaptic nTS neuronal ionotropic AMPA glutamate receptors to control neuronal and synaptic activity and modulate basal and chemoreflex cardiorespiratory function.
Methods

Ethical approval and animals
All experiments were conducted following the National Institutes of Health Guide for the Care and Use of Laboratory Animals guidelines and protocols were approved by the University of Missouri Animal Care and Use Committee. Male Sprague-Dawley rats (Envigo, Indianapolis, IN, USA) aged 4-8 weeks were used for all experiments. Animals were housed with a 12:12 h light-dark cycle with food and water available ad libitum. and crushed distally. The right Phr nerve was cut and rats underwent bilateral cervical vagotomy to prevent entrainment of phrenic motor output with the ventilator. Ground wires were sutured to the surrounding muscle to reduce noise and incisions were closed.
SSNA and phrenic nerve activity (PhrNA) was amplified (1000×), filtered (30-3000 Hz, P511, Grass technologies, Warwick, RI, USA), rectified and integrated (time constant: phrenic, 100 ms; splanchnic, 28 ms) using a root mean square converter; sympathetic nerve activity was electronically averaged. Background noise was determined from the signal between bursts of activity and verified following euthanasia. SSNA and PhrNA were defined as the respective recorded nerve activity minus background noise. The pulsatile arterial pressure signal was used to determine mean arterial pressure (MAP) and heart rate (HR) (PowerLab data acquisition system; ADInstruments, Colorado Springs, CO, USA). Minute phrenic activity (Min PhrNA) was defined as the product of phrenic frequency and amplitude. SSNA responses were evaluated as a percentage of baseline activity prior to a given intervention. nTS microinjections. Rats were placed in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA, USA) and the dorsal surface of the medulla was exposed via a partial occipital craniotomy. At the completion of surgical procedures, anaesthesia was converted over 20-30 min from isoflurane to inactin (100 mg kg −1 I.V., 5-10 mg kg −1 I.V. supplements as required). Animals were subject to neuromuscular blockade with gallamine (12.5 mg kg −1 I.V., 0.3-0.45 mg h −1 I.V. maintenance). Adequate plane of anaesthesia was verified regularly by lack of cardiovascular responses (<5 mmHg increase in arterial pressure) to firm tail pinch. The animal was allowed ß60 min for cardiorespiratory parameters to stabilize before initiating any experimental procedures. Glass micropipettes (1-3 barrels, ß10 μm per barrel, borosilicate glass, WPI) filled with appropriate solutions were advanced into the nTS. Microinjections were targeted to the caudal nTS, known to be involved in cardiorespiratory control (relative to calamus scriptorius (CS, mm): 0.0 and 0.4 rostral, 0.2 and 0.4 lateral, 0.4 ventral to the dorsal surface of the medulla) and comparable to in vitro recordings (Ostrowski et al. 2014) . Injection volumes were monitored using a compound microscope (×150).
Protocols. Initial baseline depressor, SSNA and PhrNA responses to unilateral nTS microinjections of glutamate (3-5 mM, 30 nl) were determined, to functionally identify the cardiorespiratory nTS (Foley et al. 1998; Clark et al. 2011; . To assess the tonic cardiorespiratory effects of basal nTS EAAT2, rats were subjected to bilateral injections of increasing doses of the EAAT2-selective (Alexander et al. 2011) antagonist dihydrokainate (DHK, 0.5-5 mM; ࣘ90 nl). Similar volumes of artificial cerebrospinal fluid (aCSF) served as vehicle controls. Following evaluation of concentrationresponse curves to DHK, all additional experiments were conducted using a concentration of 2 mM.
Cardiorespiratory effects of EAAT2 blockade are likely to be due to increased nTS glutamate (see Results). To assess the specific ionotropic glutamate receptor(s) (iGluRs) mediating these responses, DHK (2 mM) was microinjected alone or following application of similar volumes of iGluR antagonists. The nonselective iGluR antagonist kynurenic acid (Kyn, 40 mM) was administered to block both NMDA and non-NMDA (likely AMPA) iGluRs, followed 5 min later by injection of DHK. Similarly, the selective NMDA (2-amino-5-phosphonopentanoic acid; AP5; 10 mM) or AMPAR (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo [f]quinoxaline-2,3-dione; NBQX; 2 mM) antagonists were microinjected 5 min prior to injection of DHK.
To determine if reducing extracellular glutamate uptake by EAAT2 blockade potentiates cardiorespiratory responses to exogenous glutamate, the MAP, SSNA and PhrNA responses to unilateral glutamate microinjection (3-5 mM, 30 nl) were evaluated. DHK subsequently was microinjected and 5 min later, injections of glutamate were repeated. Following recovery (ß30 min), responses to glutamate were again evaluated.
Because the arterial chemoreflex requires glutamatergic mechanisms in the nTS, we examined the role of EAAT2 in modulating chemoreflex function. Peripheral chemoreceptors were activated by injection of NaCN (75 μg kg −1 , I.V. 
Extracellular neuronal recordings
To analyse effects of EAAT2 blockade on nTS neuronal activity in vivo, extracellular action potentials from nTS neurons were recorded using double-or triple-barrel glass micropipettes. Surgical preparations were as described above. One barrel contained 3 M NaCl for recording purposes (resistance = 10-20 M ) and the others were filled with DHK (2 mM), aCSF and/or kynurenic acid (Kyn, 40 mM). The nTS was searched (relative to CS (mm): rostrocaudal: −0.5 to +0.3; mediolateral: −0.5 to +0.5; and 0.3 to 0.7 ventral to the dorsal surface of the medulla) for spontaneously active units. Action potentials were amplified, filtered (30-3000 Hz) digitized and stored for analysis off-line (PowerLab). Neurons were tested for responses to chemoreflex activation with NaCN (50-75 μg kg −1 , I.V.) and only chemosensitive neurons underwent further evaluation. Following baseline recording, DHK (2 mM, <3 nl) was ejected and action potential discharge was monitored. To determine if responses to DHK were mediated by iGluRs, in a subset of neurons Kyn was ejected followed 5 min later by ejection of DHK.
Analysis. Action potentials were analysed off-line using PowerLab software. In all recordings, units were identified and verified as being from the same neuron. This was accomplished using the Spike Histogram discrimination module within PowerLab. For action potentials that exceeded a threshold set in a window discriminator, single units were overlaid, identified as having similar waveforms, and then manually confirmed. Ratemeter records of cell discharge (bin size: 0.5 s) were constructed. Baseline action potential discharge frequency was defined as the average of 30 s under control conditions. Responses to DHK or aCSF were determined as the peak frequency (1 s average) following injection.
Evaluation of synaptic and neuronal properties
In vitro nTS slice preparation and electrophysiology. Rats were anaesthetized with isoflurane, decapitated, the brainstem rapidly removed, its ventral surface trimmed and placed in ice-cold N-methyl-D-glucamine (NMDG) aCSF cutting solution (in mM: 93 NMDG, 93 HCl, 2. For electrophysiological recordings, nTS slices were transferred to a heated recording chamber (TC-344B, Warner Instruments, Hamden, CT, USA), secured with a nylon mesh harp, and superfused with recording aCSF at 32-35°C aerated with 95% O 2 + 5% CO 2 . Slices were allowed to acclimate to temperature and superfusion flow for 15-30 min prior to recordings.
Neurons or astrocytes were visualized on an Olympus BX51WI fixed stage upright microscope with DIC optics. Recording electrodes (3-6 M ) were pulled from borosilicate glass (cat. no. 8250, King Precision Glass, Inc., Claremont, CA, USA) on a horizontal pipette puller (P-97, Sutter Instruments, Novato, CA, USA). Recording electrodes were positioned using a piezoelectric micromanipulator (Burleigh PCS-6000, Thorlabs, Newton, NJ, USA). Recordings were targeted to the caudal nTS and regions comparable to in vivo microinjections (ß400 μm rostral to CS; Ostrowski et al. 2014) . Recording electrodes were filled with (in mM) 130 potassium gluconate, 10 NaCl, 11 EGTA, 10 HEPES, 1 MgCl 2 , 1 CaCl 2 , 2 MgATP and 0.2 NaGTP. Following initial rupture of the cell membrane, cell capacitance and input resistance were determined via the membrane test in Clampex 10 software. Signals were filtered at 2 kHz and acquired at 10 kHz using a Multiclamp 700B amplifier controlled by Clampex 10 by a Digidata 1440 interface (Molecular Devices, Sunnyvale, CA, USA).
Neuronal recording. To examine synaptic and holding currents, neurons were voltage clamped at −60 mV. TS-evoked EPSCs (TS-EPSCs) were induced by placing a concentric bipolar stimulating electrode (FHC, Bowdoin, ME, USA) on the TS afferent bundle and stimulating at 0.5 or 20 Hz. Spontaneous EPSCs (sEPSCs) and holding currents were recorded in gap-free mode without TS stimulation. Membrane potential (V m ) was recorded in current-clamp mode without holding current (I = 0). Subsequently, the role of EAAT2 blockade by DHK on cell properties was examined.
Recorded neurons, typically one to two cell layers deep, were exposed to agonists or antagonists for a minimum of 5 min and were bracketed by an aCSF baseline and wash unless otherwise noted. We examined concentration-related effects of EAAT2 blockade (100, 300 and 600 μM DHK), effects of repeated EAAT2 block (300 μM DHK), and contribution of iGluRs to EAAT2-induced effects (100 μM AP5, 25 μM NBQX, or 2 mM Kyn).
Astrocyte recordings. To record EAAT2 transport activity from astrocytes, seven rats received tail-vein injections of sulforhodamine-101 (SR-101, 20 mg kg −1 in saline) 2 h prior to slice preparation (Appaix et al. 2012) . SR-101 is a fluorescent marker that preferentially labels astrocytes (Nimmerjahn et al. 2004; Kafitz et al. 2008) . Slices were maintained in the dark during the recovery period. SR-101 positive astrocytes were visualized using fluorescence filters (Cy 3.5, Semrock, Rochester, NY, USA) and DIC optics. Astrocytes were electrophysiologically verified (Steinhauser et al. 1992; Matthias et al. 2003) based on a hyperpolarized resting membrane potential compared to nTS neurons, lack of evocable action potentials, and an ohmic response to increasing depolarizing current steps (-40 to +140 pA, 100 ms per 20 pA step). The contribution of EAAT2 in astrocytes was examined using 300 μM D-aspartate to evoke inward currents. D-Aspartate is transported by EAATs, is metabolically inert, does not activate glutamate receptors, and does not induce a current in nTS neurons (Hsu et al. 2001; Huda et al. 2013 ). D-Aspartate was superfused first alone and then in the presence of 300 μM DHK.
Analysis. In vitro electrophysiological data were analysed with Clampfit 10 (Molecular Devices) and Microsoft Excel software. Only nTS cells connected to TS-afferents with a single synapse (i.e. monosynaptic, jitter, <300 μs) were included in this study (Ostrowski et al. 2014; . The mean baseline electrophysiological properties of nTS neurons consisted of a capacitance of 20 ± 1.6 pF and input resistance of 617 ± 50 M . Stimulation of the solitary tract (TS) produced TS-EPSCs with a latency of 3.9 ± 0.3 ms and jitter of 141 ± 13 μs. sEPSC detection was set at 2× the root-mean-square noise level, and currents were manually confirmed. TS-EPSC properties per experimental treatment (baseline, DHK, wash) were determined for each individual event over 30 sweeps at 0.5 Hz, and then averaged. TS-EPSC decay time was determined from a single exponential function of the averaged trace for each treatment (τ ). Sustained inward currents following 10 TS-EPSCs at 20 Hz were examined over 300 ms following the last TS-EPSC by integrating the area under the curve. Asynchronous EPSCs (aEPSCs) were quantified as the number of sEPSCs over 300 ms following the 20 Hz stimulus train relative to the number of events 300 ms prior to the stimulus train.
Liquid chromatography-mass spectrometry for measurement of nTS glutamate concentration
To determine the degree to which EAAT2 blockade increased glutamate concentration in the nTS, 15 μl samples of aCSF were taken and analysed by the Vanderbilt University Neurochemistry Core (Nashville, TN, USA). Briefly, nTS slices (generated as above) from five rats were transferred to a custom made static bath with 500 μl of aCSF with 95% O 2 + 5% CO 2 blown across the surface. Slices rested on a nylon mesh platform and were covered by a custom made nylon thread harp. Samples (15 μl) were taken from aCSF baseline and 10 min after 300 μM DHK application. The bath was then washed three times with aCSF and another sample taken. Between sampling the bath was placed on a laboratory shaker to ensure continuous mixing. Blank non-tissue controls consisted of 15 μl of aCSF alone and 15 μl of 300 μM DHK in aCSF. Samples were immediately frozen on dry ice, and stored at −80°C until measurement.
Immunohistochemistry to localize EAAT2
Immunohistochemistry was performed as previously described (Clark et al. 2011; King et al. 2012; . Briefly, isoflurane anaesthetized rats were transcardially perfused with 0.01 M phosphate buffered saline (PBS) (ß100-200 ml, pH 7.4) followed by 4% paraformaldehyde (Sigma-Aldrich, St Louis, MO, USA; 500 ml, pH 7.4). The brainstems were removed and sectioned in the coronal plane at 30 μm. Antigen retrieval was performed on free-floating sections with citrate buffer solution (30 min, pH 6.0). Sections were rinsed (3 × 10 min) in 0.01 M PBS and blocked by 10% normal donkey serum (NDS; cat. no. S30, Millipore, Billerica, MA, USA) in 0.3% Triton X-100-PBS. Tissue sections were rinsed and subsequently incubated with primary antibodies against EAAT2 (rabbit anti-EAAT2; ab41621, Abcam, Cambridge, MA, USA; RRID no.: AB 941782, 1:250) and vesicular glutamate transporter 2 (VGluT2) (mouse anti-VGluT2; 75-067, Antibodies, Inc, Davis, CA, USA; RRID: AB 2239153, 10 μg ml −1 ) or S100beta (mouse, anti-S100beta; Abcam AB66028, RRID: AB 1142710, 1:500) with 3% NDS in 0.01 M PBS. The next day, sections were rinsed and incubated for 2 h in appropriate fluorescent secondary antibodies (all from Jackson ImmunoResearch Laboratories, West Grove, PA, USA) in 3% NDS and 0.3% Triton X-100-PBS. Sections were rinsed, mounted on gelatin-coated slides, air dried and coverslipped. Slides were then sealed with nail polish. One section per run was incubated without primary antibody and served as negative control. No staining was present on negative controls.
Immunoreactivity was examined with a conventional fluorescence microscope (BX51, Olympus) equipped with J Physiol 595.17 a digital monochrome camera (ORCA-ER, Hamamatsu) and a spinning disk confocal unit (Olympus). Appropriate filter sets and excitation wavelengths were used to visualize the fluorophores. For each fluorophore used, z-stacks (0.1 μm separation) were taken in the same focal planes. z-Projections were made from the stacks and the images were post-processed for contrast and brightness and background subtracted using FIJI (Image J) imaging software (Max Plank Institute of Molecular Cell Biology and Genetics; RRID: SCR 002285).
Reagents
DHK, NBQX (AMPAR blocker) and AP5 (NMDAR blocker) were purchased from Tocris Bioscience (R&D Systems, Inc., Minneapolis, MN, USA). Stocks of 25 mM DHK, 100 mM NBQX and 10 mM AP5 were made in double distilled water and diluted in aCSF to reported concentrations. Kyn was purchased from Sigma-Aldrich. Stocks of 75 mM Kyn were made in DMSO using 1 M equivalent NaOH to solubilize. All other chemicals were purchased from Sigma-Aldrich and Fisher Scientific (Pittsburgh, PA, USA).
Statistical analysis
The effects of DHK on synaptic, neuronal or cardiorespiratory parameters were statistically evaluated by SigmaPlot 12.5 (Systat Software, San Jose, CA, USA) and GraphPad Prism 7 (GraphPad Software, La Jolla, CA, USA). In vivo data evaluating effects of DHK on cardiorespiratory parameters or action potential discharge were analysed using one-or two-way ANOVA with or without repeated measures as appropriate. The overall response (area under the curve) to glutamate under control conditions, following DHK and after recovery was compared as above. For in vitro protocols, the group effect of DHK on TS-EPSC amplitude, holding current, action potential discharge, root mean square (RMS), and sEPSC amplitude and frequency was compared among treatments using one-way repeated measured ANOVA. Interevent intervals and sEPSC amplitude within an individual cell between baseline and DHK were tested with the Kolmogorov-Smirnov two-sample test. For both in vitro and in vivo data, differences among concentrations were compared using one-way ANOVA. As multiple experiments included an initial testing of the 2 mM (in vivo) or 300 μM (in vitro) DHK response, these data were pooled for analysis of that specific concentration. In order to have a balanced design with the other concentrations utilized, statistical comparison of concentration effects used a subset of this pooled 2 mM or 300 μM data selected at random. Fisher's LSD post hoc test was used to identify individual differences among groups where appropriate. All group data are presented as means ± SEM. Results were considered significantly different at P values < 0.05.
Results
EAAT2 tonically restrains cardiorespiratory parameters and neuronal excitation
Concentration-dependent excitation after EAAT2
blockade. To examine the influence of EAAT2 in the nTS on basal cardiorespiratory function, the EAAT2-selective antagonist DHK (0.5 -5 mM) was microinjected bilaterally into the nTS. DHK decreased cardiovascular and respiratory parameters in a concentration-related manner (Fig. 1) . A representative example of responses to 2 mM DHK is shown in Fig. 3A . DHK (2, 3 and 5 mM) significantly reduced MAP, HR and SSNA compared to aCSF control ( Fig. 1A-C) . Likewise, DHK significantly diminished Min PhrNA via reductions in both frequency and amplitude of PhrNA ( Fig. 1D-F ). Neither aCSF nor 0.5 mM DHK significantly altered cardiorespiratory function. The effects of EAAT2 block were greater as DHK concentration increased, with the greatest responses occurring at 5 mM DHK. To examine potential cellular mechanisms mediating these in vivo responses, DHK was applied to nTS slices. DHK (100-600 μM, 5 min) produced concentrationrelated inward currents ( Fig. 2A and B) and depolarized membrane potential (V m , Fig. 2C ). The inward current was significantly increased by all DHK concentrations compared to their respective aCSF baselines. While there was a significant depolarization of V m following 100 and 600 μM DHK, 300 μM DHK did not reach significance in the five cells chosen at random. This was due to a single hyperpolarized neuron; if excluded, the depolarization was significant for the remaining four recordings (P = 0.009). Likewise the pooled data set for 300 μM DHK (n = 28) indicates the depolarization was significant (see below).
To verify that EAAT2 blockade increases extracellular glutamate concentration ([Glu] e ), we measured glutamate in the tissue bath prior to, during and after exposure to 300 μM DHK in brainstem nTS slices (Fig. 2D, left) . DHK increased bath glutamate concentration compared to aCSF baseline and this effect was readily reversible upon wash. Glutamate concentration was negligible in blank non-tissue controls that consisted of either aCSF or 300 μM DHK.
Together these data demonstrate that EAAT2 blockade produced concentration-related changes in cardiorespiratory function and cellular depolarization associated with enhanced [Glu] e within the nTS. Based on the data obtained in the initial experiments, for the remainder of the study we utilized either 2 mM (in vivo) or 300 μM (in vitro) DHK.
EAAT2 alters cardiorespiratory and neuronal properties.
To more fully determine the functional role of EAAT2 in nTS, responses were examined from a total of 38 rats that were administered 2 mM DHK as part of different protocols. As in the concentration-response experiments, the representative example (Fig. 3A) shows that EAAT2 blockade by 2 mM DHK reduced MAP, HR, SSNA and frequency of PhrNA. Effects on Phr amplitude were variable with some animals exhibiting a small increase or no change in amplitude. Nevertheless, the mean data ( Fig. 3B-G ) demonstrated the overall effect was a significant reduction of Phr amplitude, resulting in decreased Min PhrNA, similar to the decrease in other cardiorespiratory parameters. These responses are similar to those of glutamate microinjection and consistent with effects previously demonstrated by blockade of EAATs 1-4 with DL-threo-β-benzyloxyaspartic acid (TBOA; . All variables except Phr frequency recovered to baseline within 5 min. Phr frequency returned to baseline within 30 min.
A total of 28 nTS neurons from 20 animals was examined prior to and after EAAT2 block. DHK (300 μM, 5 min) induced a significant depolarizing inward current (Fig. 4A ), membrane potential ( Fig. 4B ) and increase in RMS noise (Fig. 4C) , consistent with our initial dose-response studies. EAAT2 blockade also evoked a significant increase in sEPSC frequency (Fig. 4D-F ) with no significant change in spontaneous current amplitude (baseline (BL) −14 ± 0.9 pA vs. DHK −13.6 ± 1.0 pA, Student's paired t test).
Previously we confirmed EAAT2's presence on astrocytes within the nTS consistent with other studies (Chounlamountry & Kessler, 2011; Huda et al. 2013) . We examined further the distribution of EAAT2 with respect to glutamatergic terminals identified by the presence of VGluT2 (Fig. 4G) . EAAT2 surrounded VGluT2-positive puncta, but did not show co-localization. These results are consistent with EAAT2 being located on astrocytes and closely associated with VGluT2 on neuronal terminals.
EAAT2 block enhances action potential discharge.
EAAT2 blockade produced responses consistent with nTS excitation. To directly evaluate this possibility, we examined the effects of DHK on action potential discharge both in vivo and in vitro. Extracellular recordings in the whole animal were obtained from chemosensitive nTS neurons, as determined by increased action potential frequency in response to chemoreflex stimulation with NaCN (50-75 μg kg −1 , I.V.). As shown in the original traces ( Fig. 5A and B) , injection of very small volumes (<3 nl) of DHK (2 mM) increased action potential frequency whereas aCSF had no effect. In contrast to global nTS microinjection of 45-90 nl (see Fig. 3 ), these smaller volumes of DHK had no effect on arterial pressure, SSNA or PhrNA (Fig. 5A ). Mean data (Fig. 5C ) indicate that Microinjection of increasing concentrations of the EAAT2 blocker DHK (0.5 mM, n = 6; 2 mM, n = 9; 3 mM, n = 7; 5 mM, n = 5, 4 for SSNA) decreased mean arterial pressure (MAP, A), heart rate (HR, B), splanchnic sympathetic nerve activity (SSNA, C), and phrenic (Phr) nerve frequency (Freq, D), amplitude (Amp, E) and minute activity (Min PhrNA, F) . aCSF (n = 7) had no effects. One-way ANOVA. Relative to aCSF and 0.5 mM DHK: * P < 0.05, * * P < 0.01, * * * P < 0.001. Relative to 2 mM DHK: † P < 0.05, † † P < 0.01, † † † P < 0.001. Relative to 3 mM DHK: ‡ P < 0.05.
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injection of aCSF vehicle did not alter the frequency of action potential discharge. In contrast, DHK significantly increased discharge frequency, and this effect recovered. To confirm the effects of EAAT2 block were due to activation of iGluRs, in a subset of neurons we evaluated the effects of DHK before and after application of Kyn (40 mM, < 3 nl). As shown in Fig. 5D , the DHK-induced increase in action potential discharge frequency was blocked by pretreatment with Kyn. We also examined the effects of DHK on action potential discharge in the slice. Figure 5E shows a representative example in which DHK (300 μM) induced depolarization and spontaneous action potential discharge. In these experiments, DHK depolarized nTS neurons from −59.9 ± 2.6 to −47.8 ± 2.1 mV (P < 0.01, one-way repeated measures (RM) ANOVA), which partially recovered to −52.0 ± 2.9 mV with wash. Subsequently, DHK significantly increased action potential discharge (Fig. 5F ). This effect also partially recovered following wash.
EAAT2 block does not alter TS-evoked currents.
In a subset of neurons in which glutamatergic synaptic currents were evoked via stimulation of the solitary tract (TS), EAAT2 blockade did not alter TS-EPSC amplitude or decay time when evoked at 0.5 Hz (Fig. 6A-C) . When stimulation frequency was increased to 20 Hz (10 events), DHK (300 μM) again had no effect on TS-EPSC amplitude (not shown). Repetitive TS stimulation increases the frequency of spontaneous currents after the last evoked current to a level above basal sEPSCs (i.e. asynchronous (a)EPSCs; Kline et al. 2005 Kline et al. , 2007 , and may cause sustained inward depolarizing currents (Huda et al. 2013; Zhao et al. 2015) . While we observed aEPSCs following the 20 Hz TS-currents, DHK did not alter the number of aEPSCs (Fig. 6D) , nor the magnitude of sustained inward currents (Fig. 6E) .
Together these data indicate that EAAT2 blockade in the nTS results in depressor and sympathoinhibitory responses accompanied by reduced respiration in anaesthetized rats as well as increased excitation of nTS neurons in rat brainstem slices and the intact animal, consistent with responses to glutamate. However, EAAT2 blockade did not substantially alter TS-evoked synaptic release, suggesting that the in vitro effects are likely to be due to activation of extrasynaptic glutamate receptors.
EAAT2 is functional on nTS astrocytes
EAAT2 in nTS astrocytes has been identified previously by us and others (Chounlamountry & Kessler, 2011; . The soma of astrocytes positively labelled for S100B can be seen in Fig. 7A (magenta) . Note that EAAT2 (green) surrounds neurons and can be seen to colocalize (white) with S100B positive processes. To directly examine the contribution of EAAT2 to glial glutamate uptake and associated neuronal activity in the 
EAAT2 inhibition depolarizes nTS neurons and increases ambient glutamate in a concentration-dependent manner
A, bath application of the EAAT2 blocker DHK (100-600 μM, 5 min) induces inward excitatory currents. Traces are from three individual neurons. B and C, group data demonstrating DHK-induced inward currents (B) or membrane depolarization (C). n = 5 each. Student's paired t test, relative to their respective baseline (BL; aCSF): * P < 0.05, * * P < 0.01. One-way ANOVA, relative to the indicated concentration: nTS, we recorded from SR-101-labelled nTS astrocytes (Fig. 7B) . Morphologically, SR-101 positive cells in the acute slice appeared similar to astrocyte somas delineated by S100B in fixed tissue. Consistent with mature astrocyte properties in other central nuclei (Kafitz et al. 2008) , nTS astrocyte V m was significantly more hyperpolarized than neuronal V m (−71 ± 1.4 mV, n = 8 vs. BL RMP in Fig. 4B , unpaired t test P = 0.0014), and produced a near ohmic response lacking action potentials in response to current injection (not shown). Astrocyte EAATs co-transport D-aspartate (D-Asp) with sodium to produce an inward current (Danbolt, 2001; Huda et al. 2013) . Superfusion of 300 μM D-Asp resulted in a significant inward current. After EAAT2 block with 300 μM DHK, the D-Asp-mediated inward current was reduced and was not significantly different from the holding current for DHK alone ( Fig. 7C  and D) .
Responses to EAAT2 blockade are predominantly mediated by AMPA receptors EAAT2 blockade produces effects associated with increased [Glu] e . To determine the contribution of ionotropic glutamate receptors (iGluRs) to the effects of EAAT2 blockade, we examined responses to DHK in the presence and absence of general and specific iGluR antagonists.
As shown in Fig. 3 , nTS microinjection of DHK decreased baseline cardiorespiratory parameters. Prior iGluR blockade with Kyn (40 mM) resulted in pressor responses, sympathoexcitation and variable changes in PhrNA (Vardhan et al. 1993a; Mueller & Hasser, 2006; Braccialli et al. 2008; Costa-Silva et al. 2010) . Kyn attenuated the response to DHK for all cardiorespiratory parameters examined (Fig. 8A) . In order to determine the contribution of specific iGluRs, rats were injected Initial nTS slice experiments verified that repeated exposure to DHK produced similar responses. There was no significant difference produced by the first or second DHK application in the amount of inward current (DHK1, 5 ± 1 pA vs. DHK2, 9 ± 4 pA) or depolarizing V m shift (DHK1, 9.5 ± 2 mV vs. DHK2, 13 ± 6 mV). In nTS slices, antagonism of iGluRs with Kyn (1 mM) blocked the DHK-induced current (Fig. 9A) . In order to more precisely determine the contribution of specific iGluRs to the DHK-induced current, nTS neurons were first exposed to a combination of NBQX and AP5. Like Kyn, block of AMPA and NMDA receptors significantly attenuated the DHK-induced inward current (Fig. 9B) . Blockade of AMPA glutamate receptors with NBQX alone also significantly attenuated the DHK-induced current (Fig. 9C) . On the other hand, the DHK-induced current was not altered in the presence of NMDA blockade with AP5 (Fig. 9D ). Mean data (Fig. 9E) show NBQX with AP5 and NBQX alone blunt responses to DHK. Together, these results suggest most of the nTS-mediated cardiorespiratory and neuronal effects observed during EAAT2 blockade are due to activation of AMPA receptors.
EAAT2 blockade enhances cardiorespiratory responses to glutamate
As demonstrated above, DHK microinjection in the nTS has similar effects to glutamate microinjection, namely reductions in MAP, HR, SSNA and minute phrenic activity. Previously we demonstrated that blockade of EAATs 1-4 with TBOA enhances the effects of glutamate microinjection whereas aCSF vehicle had no effect . To determine if EAAT2 blockade alone is sufficient to enhance responses to exogenous glutamate, we microinjected glutamate unilaterally (3-5 mM, 30 nl) before and after administration of DHK. As with TBOA , the effects of exogenous glutamate were more sustained after DHK, and therefore we examined the overall response by integrating the changes with 
. Inhibition of EAAT2 increases nTS neuronal activity
A, original recordings in the whole animal showing application of small volumes (< 3 nl) of DHK (2 mM) increased single unit activity without affecting arterial pressure (AP), splanchnic sympathetic nerve activity (SSNA) or phrenic (Phr) nerve activity, suggesting effects on few nTS neurons. Inset shows an overlay of all action potentials in the trace. B, representative examples demonstrating application of aCSF had no effect on frequency of action potential discharge (APD, left), while DHK increased the rate of discharge (right). Note that in each of these cases, injection reduced the amplitude of recorded action potentials, presumably due to brief movement of the cell away from the electrode. In all cases we verified that recordings are from the same neuron via waveform matching within the Spike Histogram module of PowerLab, and then confirmed manually. The inset in each example shows an overlay of all action potentials in the trace. Scale bar = 1 ms. C, mean data indicating that aCSF (n = 14) had no effect on APD frequency relative to baseline (BL) whereas DHK (n = 12) increased APD frequency followed by recovery J Physiol 595.17 (Rec) . D, mean data indicating that DHK-induced neuronal excitation was blocked by the general iGluR antagonist kynurenic acid (Kyn, 40 mM, n = 6). Two-way RM ANOVA (C and D), relative to baseline (BL): * * * P < 0.001. E, representative example of membrane potential recorded in the nTS slice preparation under baseline conditions (membrane potential, −57 mV), during DHK (300 μM) and wash. Recordings were made in current clamp mode with no holding current. F, mean data indicate DHK increased APD, which decreased during wash (n = 11). One-way RM ANOVA, relative to baseline (BL): * P < 0.05.
respect to time. Following EAAT2 blockade the integrated depressor and bradycardic responses were enhanced by approximately 25% and 40%, respectively, although this did not reach statistical significance (Fig. 10A and B) . DHK significantly augmented the overall SSNA and Min PhrNA (due to both greater Phr frequency and greater Phr amplitude) responses to glutamate (Fig. 10C-F ). These results demonstrate EAAT2 blockade enhances nTS mediated responses to glutamate.
EAAT2 block enhances the chemoreflex
The peripheral chemoreflex enhances breathing and sympathetic nerve activity to maintain O 2 delivery to tissues. Since the chemoreflex is mediated by glutamate . EAAT2 block has no effect on TS-evoked currents A, representative example of TS-evoked EPSCs in the presence of aCSF (baseline, BL) and after EAAT2 block with DHK. Note the modest increase. B, group data (n = 8) of TS-EPSC amplitude under BL, DHK and washout shows no significant effect on TS-EPSC amplitude. C, decay time (τ 90-10 ) of TS-EPSCs was not altered by EAAT2 block. D, following a 20 Hz (10 events) TS stimulation, the number of events (asynchronous (a)EPSCs) was significantly elevated in both BL and DHK. There was no difference between aEPSCS in DHK (filled bars) compared to BL (open bars). Pre, currents prior to 20 Hz stimulation; Post, currents following 20 Hz stimulation. The increase in currents post-train compared to pre-train, represents aEPSCs. Two-way RM ANOVA, Post-stimulus relative to Pre-stimulus: * * P < 0.01, * * * P < 0.001. E, the magnitude of inward current after the 20 Hz stimulus train, as represented by the integrated area, was not altered by EAAT2 block. One-way RM ANOVA (B, C and E).
in the nTS, and DHK enhanced discharge in chemosensitive neurons (see Fig. 5 ), we determined the extent to which EAAT2 modulates cardiorespiratory responses to chemoreflex stimulation by NaCN (75 μg kg −1 , I.V.). As shown in the representative example, under baseline (Pre-DHK) conditions chemoreflex activation increased MAP, PhrNA and SSNA. EAAT2 blockade enhanced these responses (Post-DHK, Fig. 11 ). Mean data indicate DHK significantly augmented the pressor, tachycardic, sympathoexcitatory and phrenic nerve activity responses to chemoreflex activation (Fig. 11, filled bars) . In contrast, chemoreflex responses to NaCN were not altered in rats given aCSF (Fig. 11, open bars ). These data demonstrate that EAAT2 tempers cardiorespiratory responses to peripheral chemoreflex activation.
Discussion
The nTS is the major integration site for visceral afferent inputs, including cardiorespiratory afferents, and plays a crucial role in autonomic and ventilatory control. The role of nTS astrocytes in modulating synaptic and neuronal function is not well understood, nor are the consequent effects on cardiorespiratory control. Many kinds of ligand-binding receptors have been identified on astrocytes and astrocytes have been demonstrated to release a variety of neuroactive substances via multiple mechanisms (Perea et al. 2009 ). Of particular interest is the transport of glutamate, which is mediated by excitatory amino acid transporters. This study demonstrates that the astrocyte glutamate transporter EAAT2 tonically buffers [Glu] e . Such buffering reduces activation of extrasynaptic AMPA receptors, nTS network activity, neuronal depolarization and action potential discharge. EAAT2 modulation of [Glu] e tonically modulates basal cardiorespiratory function. Furthermore, EAAT2 tempers cardiovascular, autonomic and ventilatory responses to peripheral chemoreflex activation. Taken together, these data demonstrate that nTS astrocyte transporters regulate glutamate signalling and neuronal excitability via AMPARs to shape baseline and reflex cardiorespiratory function.
Consistent with our previous study ) and others (Tashiro & Kawai, 2007; Chounlamountry & Kessler, 2011) , EAAT2 was highly expressed throughout the nTS, including surrounding VGluT2-labelled (glutamatergic) terminals, and thus is well positioned to modulate synaptic and neuronal function. EAAT2 is believed to be the primary glial glutamate transporter in the nTS, with its location within the astrocytic cell body and processes (Tashiro & Kawai, 2007) . Our demonstration of EAAT2 expression at or near glutamatergic synapses at the light microscopy level is consistent with electron microscopy studies demonstrating EAAT2 near asymmetric (putative glutamate) terminals in the nTS. Of note, EAAT2-expressing astrocytes cover, on average, less than half of nTS synapses (although the extent of coverage is highly variable) leaving open routes for glutamate to escape the synapse and activate extrasynaptic targets (Chounlamountry & Kessler, 2011) . Modelling studies (Kessler, 2013) Glutamate is the primary excitatory neurotransmitter in the nTS and regulation of glutamate signalling, and its termination, is critical to basal respiratory and autonomic function and visceral afferent reflexes (Andresen & Mendelowitz, 1996) . To assess the functional role of glutamate uptake by EAAT2 in the nTS, we used the selective inhibitor DHK. We show via astrocyte recording that DHK substantially attenuated the inward currents produced by application of D-Asp, which is transported by EAATs. Thus, EAAT2 contributes importantly to transporter function, although the lack of complete block by DHK suggests other EAATs, presumably EAAT1, may also play a role. These results are consistent with other nTS studies demonstrating a functional role of EAATs on astrocytes (Huda et al. 2013) . In addition, inhibition of EAAT2 function increased ambient [Glu] e , demonstrating EAATs tonically buffer nTS glutamate levels. The fact that responses to DHK mimicked those of nTS microinjection of glutamate, and DHK enhanced responses to exogenous glutamate is also consistent with reduced glutamate buffering following EAAT2 blockade. The source of glutamate was not determined, but it could originate from sensory afferents, interneurons and/or terminals from other central nuclei. An alternative explanation is that DHK may also increase levels of taurine, as occurs in the hippocampus (Lehmann & Hamberger, 1983) . However, taurine induces neuronal hyperpolarization either through activation of specific taurine receptors or via an interaction with glycine or GABA receptors (Albrecht & Schousboe, 2005; Wu & Prentice, 2010) . Furthermore, synaptic, neuronal and cardiorespiratory effects of DHK required ionotropic glutamate receptors, supporting the concept that they are mediated by glutamate. Thus, similar to other brain regions (Jabaudon et al. 1999) , EAATs are functional in the nTS and EAAT2 is a primary contributor to transporter function.
The physiological responses observed upon EAAT2 inhibition indicate enhanced nTS neuronal excitation. Block of EAAT2 evoked depolarizing inward currents and potentials, increased RMS noise, and enhanced action potential discharge. We previously observed similar responses upon overall EAAT inhibition with TBOA . The DHK-induced elevation of [Glu] e is likely to increase its escape from the synaptic cleft and its subsequent binding and activation of additional synaptic and extrasynaptic GluRs. The enhanced action potential discharge is likely to be due to this observed neuronal depolarization, bringing the membrane potential to action potential threshold and resulting in elevated discharge. These effects are supported by our whole animal studies demonstrating DHK-induced neuronal depolarization and increased action potential discharge which were blocked by the glutamatergic antagonist Kyn. Moreover, the increased discharge and cardiorespiratory responses consistent with excitation following DHK microinjection confirm a functional influence in the intact animal and that the increased excitability observed in slice preparations was not a consequence of the reduced preparation.
As discussed above, EAAT2-containing astrocytes ensheath postsynaptic neurons and presynaptic glutamatergic (VGluT2) terminals. Given this distribution, we expected EAAT2 inhibition to enhance EPSCs. DHK did not alter sEPSC amplitude, suggesting the presynaptic glutamate quantal content and postsynaptic conductance of GluRs in the active zone of the synapse are unaltered. However EAAT2 antagonism did increase sEPSC frequency, similar to that observed with general EAAT blockade ). This increased frequency may be due to DHK-induced depolarization of neurons within the nTS network and ultimately glutamate release from their synaptic terminals. In addition, elevated [Glu] e may directly activate presynaptic terminals that express ionotropic or metabotropic glutamate receptors to elevate glutamate release onto the recorded neurons. Such an increase in sEPSCs may also contribute to the elevated action potential discharge.
Sensory afferent (TS)-EPSC amplitude and decay were unaltered following EAAT2 blockade. Synaptically released glutamate responsible for TS-EPSCs may saturate AMPA receptors, such that additional glutamate due to EAAT blockade has no further effect. Modelling studies support a minimal effect of EAAT block on AMPA currents (Kessler, 2013) . However, in vivo studies demonstrate enhanced responses to activating chemoafferents (see below). This may have been due to greater elevations in afferent input, or to activation of more neurons. We may have observed similar effects in the slice if we had allowed V m to change and examined action potential discharge to TS stimulation. Minimal effects of DHK on TS-EPSCs were in contrast to our previous work demonstrating TBOA attenuated TS-EPSC amplitude . The observed difference between TBOA-and DHK-mediated changes in TS-EPSCs may be due to the magnitude of elevation of [Glu] e via EAAT block, and/or the mechanism by which the increase occurs. For instance, TBOA inhibits astrocytic EAAT1-2 and neuronal EAAT3 (although EAAT3 likely does not play a profound role; Chounlamountry et al. 2016) . Block of both EAAT1 and EAAT2 with TBOA may result in greater elevation of [Glu] e than EAAT2 block alone, and thus activate receptors more distal from the sensory afferent-nTS synaptic active zone to ultimately inhibit TS-EPSC amplitude (e.g. presynaptic metabotropic GluR). Conversely, the likely lesser elevation of [Glu] e by DHK may limit the magnitude of glutamate diffusion from the synaptic cleft and thus not activate the GluRs that reduce TS-EPSCs.
While the amplitude of phasic AMPAR-mediated EPSCs was not altered by EAAT2 block, AMPARs were responsible for the depolarizing tonic current upon elevation of [Glu] e . Specifically, in our slice and physiological recordings, the ionotropic GluR 
Glu
Glu Glu * ** ** ** Figure 10 . Inhibition of EAAT2 in the nTS enhances cardiorespiratory responses to glutamate Overall change (area under the curve, expressed as total change over 15 s (SSNA, PhrNA) or 20 s (MAP, HR) in cardiorespiratory variables due to nTS microinjection of glutamate (Glu) under control (Con) conditions, 5 min after nTS injection of DHK (2 mM) and after recovery (Rec, 30 min post-DHK injection). One-way RM ANOVA, relative to control response to Glu: * P < 0.05; * * P < 0.01. n = 6-8. J Physiol 595.17 blocker Kyn blocked the DHK-mediated effects. Likewise, selectively blocking AMPARs reduced or eliminated the DHK-mediated inward currents, as well as the depressor, sympathoinhibitory responses, and inhibition of breathing. Thus, these results suggest putative extrasynaptic AMPARs are activated upon elevation of [Glu] e to induce depolarization. AMPARs have been shown to contribute to sustained depolarization following high frequency stimulation (Huda et al. 2013) . Supporting activation of extrasynaptic AMPARs, electron microscope studies have localized AMPARs to non-synaptic regions in the nTS (Aicher et al. 2002; Baude et al. 2009 ). NMDARs mediate extrasynaptic currents following EAAT block in the hypothalamus (Potapenko et al. 2012 ) and contribute to currents following increased frequency stimulation in the nTS (Huda et al. 2013; Zhao et al. 2015) . The distinct contribution of the AMPAR and NMDAR in DHK-mediated events may be due to the central nucleus examined (hypothalamus vs. nTS) or the mechanism of release (e.g. frequency or duration of stimulation vs. basal glutamate release or tone). Of note, within the nTS, block of NMDARs did not alter DHK-mediated currents studied in the slice, but enhanced DHK-mediated cardiorespiratory parameters in the intact rat. Such NMDAR response differences may be due to several factors. Our slice recordings were not optimized for recording of NMDAR currents. For instance, our extracellular solutions contained Mg 2+ , which is known to block the channel pore of the NMDAR. The degree to which DHK depolarized neurons may not have exceeded the voltage needed to eliminate this Mg 2+ block (cells were held at −60 mV). Thus, in our slice recordings, the contribution of NMDARs may be underestimated. Conversely, with an intact nTS that allows influence of sensory afferents and other central nuclei in vivo, block of NMDAR may allow further activation of other GluRs to influence the balance of excitation and inhibition in the nTS, possibly via activation of pre-or postsynaptic AMPARs.
Glutamate produces an overall tonic excitation within the nTS, indicated by pressor and sympathoexcitatory responses to iGluR antagonists (Vardhan et al. 1993a; Mueller & Hasser, 2006; Braccialli et al. 2008; Costa-Silva et al. 2010) . Our data show EAAT2 tonically dampens this excitation in the intact nTS and modulates cardiorespiratory parameters, likely by buffering ambient glutamate concentrations. Similar to general EAAT blockade , EAAT2 inhibition with DHK produced depressor and sympathoinhibitory effects produced increases in arterial pressure (AP), splanchnic sympathetic nerve activity (SSNA) and phrenic nerve activity (PhrNA) that were greater following nTS microinjection of DHK (2 mM). B-G, mean data demonstrate that, compared to initial responses (Pre) to NaCN, nTS microinjection of DHK (Post) significantly enhanced mean arterial pressure (MAP; B), heart rate (HR; C), splanchnic sympathetic nerve activity (SSNA; D), and phrenic (Phr) frequency (Freq; E) and minute activity (Min PhrNA; G) responses to chemoreflex activation. Phr amplitude (Amp; F) effects of NaCN were non-significantly increased by DHK. In contrast, prior microinjection of aCSF had no effect on any cardiorespiratory response to NaCN. Two-way RM ANOVA, relative to control (Pre) response to NaCN: * P < 0.05, * * P < 0.01.
accompanied by phrenic nerve inhibition, mimicking cardiorespiratory responses to exogenous glutamate (Bonham & McCrimmon, 1990; Vardhan et al. 1993b; Foley et al. 1998) . These experiments targeted the overall mediocaudal region of the nTS, including neurons involved in chemo-and baroreceptor reflexes. When the cardiorespiratory nTS is globally activated with DHK (similar to activation by glutamate), baroreflex-like effects appear to predominate. As discussed above, the basal glutamate modulation occurs primarily through AMPA receptors, as the cardiorespiratory effects of EAAT2 blockade were inhibited by kynurenic acid and the AMPA receptor antagonist NBQX. The overall tonic effects of nTS astrocytic EAAT2 on cardiorespiratory function appear to result in buffering of baseline glutamate excitation. In addition to effects on baseline cardiorespiratory function, EAAT2 also appears to diminish the excitatory effects of further increases in nTS glutamate. This concept is supported by the enhanced or prolonged responses to exogenous glutamate microinjection following EAAT2 block in the nTS. Furthermore, cardiorespiratory responses to peripheral chemoreflex activation, which are mediated by endogenous glutamatergic mechanisms in the nTS, were augmented by prior injection of DHK. Thus, astrocytic EAAT2 blunts responses to increased glutamate in the nTS and buffers arterial chemoreflex-mediated increases in sympathetic nerve activity and breathing. EAAT2 effects are likely due to reduced nTS neuronal excitability, as EAAT2 block produced depolarization and augmented action potential discharge in nTS neurons that were excited by chemoreflex stimulation. Whether EAAT2 influences other reflex responses was not examined. Astrocyte modulation of glutamate signalling and tempered chemoreflex function may have substantial functional significance because elevated sympathetic nervous system activity and enhanced chemoreflexes are highly associated with morbidity and mortality in several cardiorespiratory diseases (Fisher et al. 2009; Andrade et al. 2015; Del Rio et al. 2015; Paton, 2017) . For example, astrocyte transporter control of hypothalamic neurons is altered in heart failure (Potapenko et al. 2012) . It is tempting to speculate that changes in nTS astrocyte transporters may likewise influence sympathetic nervous system activity and cardiorespiratory reflex function in disease.
